case_images: PMC11193922_01
case_images: Chest X-ray that showed cardiomegaly.
case_images: 10.1177_2050313X241263761-fig1.jpg
case_images: PMC11193922_01_10.1177_2050313X241263761-fig1.jpg
case_images: fig1-2050313X241263761
case_images: Chest X-ray (Figure 1) revealed enlarged heart (cardiomegaly).
case_images: Echocardiography showing reduced ejection fraction of 30% and left ventricular dilatation.
case_images: 10.1177_2050313X241263761-fig2.jpg
case_images: PMC11193922_01_10.1177_2050313X241263761-fig2.jpg
case_images: fig2-2050313X241263761
case_images: At the 2-week follow-up, the patient presented with echocardiography (Figure 2) conducted at Mulago National Specialist Hospital, revealing an ejection fraction of 30% and LV dilatation.
case_images: (a) Combining weight, respiratory rate, oxygen saturation, and medication duration. (b) Changes in brain natriuretic peptide and prolactin levels over time. (c) Clinical course, including treatment and symptom onset.
case_images: 10.1177_2050313X241263761-fig3.jpg
case_images: PMC11193922_01_10.1177_2050313X241263761-fig3.jpg
case_images: fig3-2050313X241263761
case_images: Based on clinical findings and diagnostic evaluations, the patient was diagnosed clinically with congestive heart failure secondary to postpartum cardiomyopathy, as per Framingham criteria.   Treatment was initiated with intravenous furosemide 40 mg twice daily, oral bisoprolol 5 mg once daily, oral dapagliflozin 10 mg once daily, and oral bromocriptine 5 mg once daily, with close monitoring of vital signs (Figure 3(a)). Clinical symptoms had improved, and concurrently, laboratory tests indicated a decrease in biomarkers (NT-proBNP and prolactin levels) (Figure 3(b)), suggesting a favorable trajectory in cardiac function. By the 2-month visit, the patient had become asymptomatic (Figure 3(c)), with NT-proBNP and prolactin levels decreasing further, marking a significant milestone in their recovery journey.